Join Now

Recent BioUtah News & Events

Everything Happening in Utah Life Sciences

August 4, 2022
BioUtah News
bioMérieux receives FDA Clearance for NEPHROCHECK® test on VIDAS®

bioMérieux receives FDA Clearance for NEPHROCHECK® test on VIDAS®

August 4, 2022
BioUtah News
3M Announces Plans to Create Long Term Value Through Spin-Off of Health Care Business

New 3M will remain a leading global material science innovator serving diverse end markets, with science and technology, manufacturing, global capabilities, and iconic brands

August 3, 2022
BioUtah News Policy News
Tillis and Leahy Introduce Bipartisan Legislation to Improve Patent Quality

Tillis and Leahy Introduce Bipartisan Legislation to Improve Patent Quality

July 28, 2022
Policy News
Senate Democrats Push Drug Pricing, Tax, Climate Package

Sen. Joe Manchin (D-W. Va.) on Wednesday said he had signed off on a revised “Build Back Better” plan, renamed the “Inflation Reduction Act of 2022,” which includes sweeping drug price controls along with tax increases and billions for climate and energy spending. The bill’s drug pricing provisions would allow Medicare to negotiate drug prices […]

July 28, 2022
BioUtah News
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2022

UTMD achieved second calendar quarter (2Q) and first half (1H) 2022 financial results better than those anticipated in its beginning of year projections.

July 28, 2022
BioUtah News
Sumitomo Pharma Oncology Receives Orphan Drug Designation for DSP-0390, an Investigational Emopamil-binding Protein (EBP) Inhibitor for the Treatment of Brain Cancer

Sumitomo Pharma Oncology recently announced the U.S. FDA granted Orphan Drug Designation for DSP-0390, an investigational emopamil-binding protein (EBP) inhibitor for the treatment of brain cancer. 

July 28, 2022
BioUtah News
Forbes Magazine Recognizes ARUP Among Nation’s Best Employers for Women

ARUP Laboratories’ ongoing commitment to provide an environment of diversity, inclusion, and belonging for all employees has earned the company recognition as one of Forbes magazine’s Best Employers for Women 2022. The Forbes ranking, first published online on Tuesday, July 26, places ARUP 236th on a list of 300 companies nationwide. Winners were chosen based […]

July 28, 2022
BioUtah News
Published UCLA and Spectrum Saliva Liquid Biopsy Research Highlights Signal Amplifying Ability and Clear Detection of Cancer Biomarkers

Spectrum Solutions announced the publishing of findings from their research collaboration with the University of California at Los Angeles (UCLA) and Dr. David Wong, UCLA School of Dentistry.

July 28, 2022
BioUtah News
Clene’s ALS Drug Increases Survival by 70% in Mid-stage Study

Shares of Clene, Inc. surged Thursday after the company released “golden” data from an interim analysis of a Phase II study.

July 28, 2022
BioUtah News
Merit Medical Launches Smallest and Shortest Configuration of Elation® Pulmonary Balloon Dilator to Help Meet Critical Patient Need

Only balloon configuration specifically designed to dilate small airways, providing minimally invasive treatment to patients with lung obstructions

July 27, 2022
BioUtah News
Co-Diagnostics, Inc. to Announce Expansion of OEM Agreement with Bio Molecular Systems at AACC

Co-Diagnostics announced that it will be disclosing the global expansion of its OEM agreement with Bio Molecular Systems (BMS) at the Company’s customer and distributor update today at AACC.

July 25, 2022
BioUtah News
ARUP’s New Monkeypox Test Can Be Performed on More Specimen Types on High-Throughput Instruments

SALT LAKE CITY, July 25, 2022 — ARUP Laboratories today announced that it has begun in-house testing for monkeypox. The Orthopoxvirus (includes monkeypox virus) by PCR test (test code 3005716) is a real-time polymerase chain reaction (RT-PCR) test to detect the DNA of orthopoxviruses, including monkeypox. ARUP’s test is similar to the CDC assay that […]

July 21, 2022
Industry News
BD Completes Acquisition of Parata Systems

BD (Becton, Dickinson and Company) (NYSE: BDX) today announced it has completed the acquisition of Parata Systems. Parata advances BD’s transformative solutions strategy by providing a portfolio of innovative pharmacy automation solutions that power a growing network of pharmacies to reduce costs, enhance patient safety and improve the patient experience for retail, hospital and long-term care […]

July 21, 2022
Policy News
BioUtah Joins State BIOs in Opposing Drug Price Controls

Senate Democrats are inching closer to a vote on a revived “Build Back Better” package, largely focused on drug pricing. The package would give Medicare the authority to negotiate drug prices and impose inflation rebates. The negotiation process, in practice, would function more like government price controls since drug manufacturers deemed non-compliant with the requirements […]

July 21, 2022
BioUtah News
Nexus Spine Announces Launch of Stable-C™ Cervical Interbody System with Integrated Fixation

Launch represents the company’s eighth commercial release within its line of Tranquil™ interbody fusion implants

July 14, 2022
BioUtah News
Nomi Health Opens Infant and Pediatric COVID Vaccine Location

OREM, Utah–(BUSINESS WIRE)–Nomi Health, a direct healthcare company dedicated to improving access and lowering costs in the healthcare system, today opened their first location for infant and pediatric COVID vaccine services at West Valley City Centennial Park. To ensure the safest and most positive experience, each Nomi Health employee on site has completed extensive pediatric […]

July 14, 2022
BioUtah News
Nomi Health Acquires Everyone Health, Sano Surgery

As Americans continue to pay more for needed medical treatments and with care costs outpacing the rate of inflation, Nomi Health — the direct healthcare company making it easier than ever to access the highest quality affordable care across the U.S.— today announced two acquisitions to bolster its support of buyers of care and their […]

July 12, 2022
BioUtah News
Co-Diagnostics, Inc. Announces Shipment of Monkeypox Virus Test

Co-Diagnostics announced that it has shipped testing reagents for monkeypox virus currently exhibiting a multi-country outbreak to one of its international distributors.

July 12, 2022
BioUtah News
Biomerics Launches Interventional Medical Plastics Division with Acquisition of Dependable Plastics

Biomerics announced the acquisition of Dependable Plastics and creation of a new division — Biomerics Interventional Medical Plastics (IMP) Division.

July 7, 2022
BioUtah News Policy News
Senate Democrats Renew Plan for Drug Price Controls

Senate Democrats have renewed a push for drug pricing reforms, releasing on Wednesday proposed legislation along with a bill summary.

July 7, 2022
Policy News
Sumitomo Pharma Oncology Receives Orphan Drug Designation for TP-3654, an Investigational Oral Inhibitor of PIM Kinases for the Treatment of Myelofibrosis

Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer therapeutics, recently announced that the FDA granted Orphan Drug Designation for TP-3654, the company’s proprietary investigational oral inhibitor of PIM kinases, for the treatment of myelofibrosis.  “This designation is an important milestone in the development of TP-3654 and highlights the need for potential new treatment […]

July 7, 2022
BioUtah News
BD Names Rishi Grover as Chief Integrated Supply Chain Officer

FRANKLIN LAKES, N.J., July 5, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Rishi Grover has been named executive vice president (EVP) and chief integrated supply chain officer for BD, effective July 7, 2022. In this role, Grover will have global responsibility for the […]

June 30, 2022
Policy News
Sumitomo Pharma Oncology, Inc. Pursues Research and Discovery with Persistence – Featured in Pharma Tech Outlook

Sumitomo Pharma Oncology, Inc. (SMP Oncology) and Steve Warner, Ph.D., Senior Vice President and Head of US Research at SMP Oncology, were recently featured in a Pharma Tech Outlook. In “Sumitomo Pharma Oncology: Discovering Immunotherapy Agents with Persistence,” Dr. Warner discusses SMP Oncology’s ongoing work in immunotherapy drug discovery, highlighting the progress with the Company’s […]

June 30, 2022
BioUtah News
Spectrum Wins Two Science & Technology Best of State Awards

Spectrum Solutions, LLC today announced it has been awarded two Utah Best of State Science & Technology Awards for Medical Innovation and Laboratory Equipment and Supplies.

June 30, 2022
BioUtah News
$10k Women’s Seed Grant Announced at Inaugural BioHive Women’s Event

On June 24, BioHive held their inaugural Women’s event sponsored by BD, BioMerieux, e4H Architects, Health Catalyst, Known Medicine, MarshMcLennan, Recursion, Seek Labs and JLL Realty. With 180 registrants from 54 companies, attendees packed over 200 STEM Kits in partnership with Utah STEM Action Center for elementary and middle school students, listened to a panel […]

June 30, 2022
BioUtah News
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2022

LONDON and SALT LAKE CITY, June 30, 2022 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, today reported financial results for the quarter ended March 31, 2022. Recent Highlights (including […]

June 29, 2022
BioUtah News
Myriad Genetics Teams Up with Epic to Make Genetic Testing Accessible to More Patients with Electronic Health Record (EHR) Integration

Healthcare providers can easily order Myriad’s genetic tests for the more than 250 million patients within Epic’s network

June 28, 2022
BioUtah News
U.S. Patent Office Grants New Patent Protection For Exoskeleton Focal-Force Angioplasty Platform

Transit Scientific achieved increased U.S. patent protection for their novel exoskeleton focal-force angioplasty technology using standard off-the-shelf peripheral transluminal angioplasty (PTA) balloons.

June 23, 2022
BioUtah News
One Utah Health Collaborative and Utah’s BioHive Community

Governor Cox has invited Utah’s life sciences industry to engage in a bold initiative called the “One Utah Health Collaborative.” Cox understands the importance of our industry to the healthcare system and it’s appropriate that we be at the table. Below we provide more detailed information about the initiative and opportunities to participate. Background Last […]

June 23, 2022
BioUtah News
Tempus Announces Research Collaboration with Intermountain Healthcare to Advance Precision Oncology Research

Tempus, a leader in artificial intelligence and precision medicine, today announced a collaboration with Intermountain Healthcare, a Utah-based, nonprofit healthcare system, which leverages genomic testing and data analytics to advance research intended to improve outcomes for cancer patients. Intermountain Healthcare is leveraging Tempus’ solid tumor/normal genomic test, xT, to generate whole transcriptomic data on existing […]

June 23, 2022
BioUtah News
KT Tape Names Jessica Klodnicki As New CEO

AMERICAN FORK, Utah, June 22, 2022 /PRNewswire/ — KT Tape®, the leader in drug-free pain relief products, today announced that after a national executive search, the company’s board of directors has appointed Jessica Klodnicki as its new chief executive officer. Klodnicki is a recognized transformative leader in the outdoor brands and consumer products industry with […]

June 23, 2022
BioUtah News
IONIQ Unveils LUNA3, Next-Generation Early-Stage Cancer Detection Platform

IONIQ Sciences unveiled its next-generation platform called LUNA3™ for early-stage cancer detection. LUNA3 is designed to accelerate the transition of cancer testing from the hospital and doctor’s office into pharmacies and ultimately into consumers’ homes.